Neoadjuvant Immunotherapy Improves Outcomes in Treatment of High-risk Liver Cancer
Patients diagnosed with liver cancer (hepatocellular carcinoma; HCC) who received immune checkpoint inhibitors (ICIs) before surgery—including those who would not...
liver
FDA Approves Gilead’s Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal – Gilead Sciences (NASDAQ:GILD)
On Wednesday, the FDA granted accelerated approval for Gilead Sciences, Inc.’s GILD Livdelzi (seladelpar) for primary biliary cholangitis (PBC) in combination with...
Ronnekleiv-Kelly Awarded Grant to Study Potential Treatment Target for Rare Form of Liver Cancer
Sean Ronnekleiv-Kelly, MD Division of Surgical Oncology Associate Professor Sean Ronnekleiv-Kelly, MD, is determined to improve treatment options for a...
Machine Learning Predicts Cancer Risk in Liver Disease Patients
A research team from UC Davis Health developed a machine learning (ML) tool to identify which patients are at increased...
Revolutionising liver transplantation: The LEOPARD Project
The new EU-funded LEOPARD project aims to transform liver transplantation by leveraging artificial intelligence to better stratify patients waiting for...
Addressing Ongoing Disparities in Liver Cancer Care: Dr Amit Singal
Amit Singal, MD, medical director of the Liver Tumor Program and chief of hepatology at UT Southwestern Medical Center, discusses...
